No abstract

Broad host-range mini-Tn7 vectors facilitate integration of single-copy genes into bacterial chromosomes at a neutral, naturally evolved site. Here we present a protocol for employing the mini-Tn7 system in bacteria with single attTn7 sites, using the example Pseudomonas aeruginosa. The procedure involves, first, cloning of the genes of interest into an appropriate mini-Tn7 vector; second, co-transfer of the recombinant mini-Tn7 vector and a helper plasmid encoding the Tn7 site-specific transposition pathway into P. aeruginosa by either transformation or conjugation, followed by selection of insertion-containing strains; third, PCR verification of mini-Tn7 insertions; and last, optional Flp-mediated excision of the antibiotic-resistance selection marker present on the chromosomally integrated mini-Tn7 element. From start to verification of the insertion events, the procedure takes as little as 4 d and is very efficient, yielding several thousand transformants per microgram of input DNA or conjugation mixture. In contrast to existing chromosome integration systems, which are mostly based on species-specific phage or more-or-less randomly integrating transposons, the mini-Tn7 system is characterized by its ready adaptability to various bacterial hosts, its site specificity and its efficiency. Vectors have been developed for gene complementation, construction of gene fusions, regulated gene expression and reporter gene tagging.

No abstract

For many bacteria, cloning and expression systems are either scarce or nonexistent. We constructed several mini-Tn7 vectors and evaluated their potential as broad-range cloning and expression systems. In bacteria with a single chromosome, including Pseudomonas aeruginosa, Pseudomonas putida and Yersinia pestis, and in the presence of a helper plasmid encoding the site-specific transposition pathway, site- and orientation-specific Tn7 insertions occurred at a single attTn7 site downstream of the glmS gene. Burkholderia thailandensis contains two chromosomes, each containing a glmS gene and an attTn7 site. The Tn7 system allows engineering of diverse genetic traits into bacteria, as demonstrated by complementing a biofilm-growth defect of P. aeruginosa, establishing expression systems in P. aeruginosa and P. putida, and 'GFP-tagging' Y. pestis. This system will thus have widespread biomedical and environmental applications, especially in environments where plasmids and antibiotic selection are not feasible, namely in plant and animal models or biofilms.

No abstract

Allelic exchange is an efficient method of bacterial genome engineering. This protocol describes the use of this technique to make gene knockouts and knockins, as well as single nucleotide insertions, deletions and substitutions in Pseudomonas aeruginosa. Unlike other approaches to allelic exchange, this protocol does not require heterologous recombinases to insert or excise selective markers from the target chromosome. Rather, positive and negative selection are enabled solely by suicide vector-encoded functions and host cell proteins. Here, mutant alleles, which are flanked by regions of homology to the recipient chromosome, are synthesized in vitro and then cloned into allelic exchange vectors using standard procedures. These suicide vectors are then introduced into recipient cells by conjugation. Homologous recombination then results in antibiotic resistant single-crossover mutants in which the plasmid has integrated site-specifically into the chromosome. Subsequently, unmarked double-crossover mutants are isolated directly using sucrose-mediated counter-selection. This two-step process yields seamless mutations that are precise to a single base pair of DNA. The entire procedure requires ~2 weeks.

No abstract

Triclosan is an antiseptic frequently added to items as diverse as soaps, lotions, toothpaste, and many commonly used household fabrics and plastics. Although wild-type Pseudomonas aeruginosa expresses the triclosan target enoyl-acyl carrier protein reductase, it is triclosan resistant due to expression of the MexABOprM efflux system. Exposure of a susceptible ⌬(mexAB-oprM) strain to triclosan selected multidrug-resistant bacteria at high frequencies. These bacteria hyperexpressed the MexCD-OprJ efflux system due to mutations in its regulatory gene, nfxB. The MICs of several drugs for these mutants were increased up to 500-fold, including the MIC of ciprofloxacin, which was increased 94-fold. Whereas the MexEF-OprN efflux system also participated in triclosan efflux, this antimicrobial was not a substrate for MexXY-OprM.Pseudomonas aeruginosa is a clinically significant pathogen, particularly in immunocompromised hosts (36). Infections caused by this bacterium are difficult to treat due to its many intrinsic and acquired antibiotic resistances. Intrinsic resistance is mostly attributable to the expression of several multidrug resistance (MDR) efflux systems. The P. aeruginosa genome (35) contains structural genes for at least 12 resistance nodulation type efflux systems, of which only 4, i.e., MexABOprM (27), MexCD-OprJ (26), MexEF-OprN (13), and MexXY (1, 21, 38), have been characterized. Exposure to selected substrates can select for their upregulated or constitutive expression (13,14,26,38).2-Hydroxyphenylethers are a class of compounds that exhibit broad-spectrum antimicrobial activity. Triclosan is the most potent and widely used member of this class (2, 5) and is used in hand soaps, lotions, toothpastes, and oral rinses, as well as in fabrics and plastics. It was long thought to act as a nonspecific "biocide" (29), but recent biochemical and genetic studies have shown that triclosan acts on a defined bacterial target in the fatty acid biosynthetic pathway, enoyl-acyl carrier protein (ACP) reductase (FabI) (7,9,10,12,18,20) or its homolog InhA in mycobacteria (18). Some bacteria possess triclosan-resistant enoyl-ACP reductase homologs (FabK), and to date P. aeruginosa is unique among gram-negative bacteria in that it possesses both triclosan-sensitive and -resistant enzymes (8). Alterations in FabI active-site residues confer resistance to triclosan (9,10,20). Of particular concern is that such amino acid changes selected by exposure to triclosan lead to cross-resistance with other antimicrobial agents (9), including clinically used front-line drugs, since some mutations leading to triclosan resistance in Mycobacterium smegmatis also caused resistance to isoniazid (18). Moreover, triclosan is a substrate of a multidrug efflux pump in clinical and laboratory Escherichia coli strains (19). We have recently shown that P. aeruginosa strain PAO1 is intrinsically resistant to triclosan by virtue of expression of the MexAB-OprM efflux pump (32), and the same is true for all strains of this species tested to date (...